Related Experiment Videos
Fumaric acid esters: an alternative systemic treatment for psoriasis.
1Skin Tumour Unit, St. John's Institute of Dermatology, London, UK.
Clinical and Experimental Dermatology
|November 17, 1999
Summary
Fumaric acid esters (FAE) effectively treated severe chronic plaque psoriasis in two patients resistant to other therapies. This systemic treatment shows promise for difficult-to-manage psoriasis cases.
Area of Science:
- Dermatology
- Immunology
- Pharmacology
Background:
- Psoriasis is a chronic inflammatory skin condition with limited treatment options for severe cases.
- Systemic therapies are often used for severe psoriasis but can have significant side effects or limited efficacy.
- Fumaric acid esters (FAE) are used in some countries for psoriasis treatment.
Observation:
- Two patients with severe chronic plaque psoriasis were treated with FAE.
- These patients had previously failed other systemic therapies for their condition.
Findings:
- Successful clearance of severe chronic plaque psoriasis was achieved in both patients following FAE treatment.
- FAE demonstrated efficacy in patients refractory to prior systemic treatments.
Implications:
- FAE represents a potential therapeutic option for severe, treatment-resistant psoriasis.
- Further research and clinical trials are warranted to establish FAE's role in psoriasis management.
- Regulatory approval of FAE for psoriasis in Britain could expand treatment accessibility.